# A Trial of HRS-1780 in Participants With Uncontrolled Hypertension or Resistant Hypertension.

> **NCT07708441** · PHASE2,PHASE3 · NOT_YET_RECRUITING · sponsor: **Shandong Suncadia Medicine Co., Ltd.** · enrollment: 914 (estimated)

## Conditions studied

- Uncontrolled or Resistant Hypertension

## Interventions

- **DRUG:** HRS-1780 tablet
- **DRUG:** HRS-1780 tablet
- **DRUG:** HRS-1780 tablet
- **DRUG:** HRS-1780 tablet placebo

## Key facts

- **NCT ID:** NCT07708441
- **Lead sponsor:** Shandong Suncadia Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09
- **Primary completion:** 2029-04
- **Final completion:** 2029-04
- **Target enrollment:** 914 (ESTIMATED)
- **Last updated:** 2026-09-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07708441

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07708441, "A Trial of HRS-1780 in Participants With Uncontrolled Hypertension or Resistant Hypertension.". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07708441. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*